The RSVital Trial is evaluating an investigational vaccine, called mRNA-1345, to determine if it may provide additional protection against RSV in adults aged 60 and older when given as a revaccination.
Did you know that flu viruses change every year? That’s why yearly vaccination is the most effective way to help prevent flu and its complications.
Your participation in the study will help to determine whether an investigational vaccine helps to provide protection against RSV in different populations.
Indago delivers community-based services for Miami and neighboring areas, driving advances in investigational research for new and improved drugs.
Working Hours
Monday-Friday 8:00 AM – 5:00 PM
Saturday (open if necessary)
Sunday (open if necessary)